top of page
Lumos Diagnostics Achieves U.S. Medicare Reimbursement Milestones for FebriDx®
Lumos Diagnostics (ASX: LDX) has taken a major step forward in its U.S. market expansion, securing Medicare reimbursement for its rapid...
3 days ago


bottom of page